Sanofi India Ltd
SANOFI (NSE)

6,430.05

14,743.28
Proj. ROE (%)
30.82
Proj. P/E (x)
-
Proj EV / EBITDA (x)
18.76
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
3,029.58

Stock View

BUY
Share on
The average score for Sanofi India Ltd stands at 6 against 7, three months back.

Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals products. The Company’s products are offered across four categories, which includes pharmaceuticals, consumer health care, vaccines and specialty care. It offers medicines for therapy areas, such as diabetes (both insulins and orals), cardiology, thrombosis, anti-infectives, central nervous system, allergy and vitamins, and minerals and supplements. Its pharmaceutical products include Adenocor, Lantus, Aldurazyme, AllStar, Amaryl MP, Amaryl M, Apidra, Arava, Aubagio and Thymoglobuline. Its specialty care products include Myozyme, Cerezyme, Aldurazyme, Aubagio and Jevtana. Its consumer healthcare products include Allegra, Allegra nasal, Avil, Combiflam, Combiflam Plus and Lactacyd. Its vaccines products include Adacel, Avaxim 80U/160U, FluQuadri, Hexaxim, Menactra, Tetraxim, Vaxigrip, Stamaril, Shanvac-B and ShanTT.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
6,739.97
100 DMA ()
7,066.44
200 DMA ()
7,479.71
52 Weeks Range
6,351.00
9,285.00
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity